28 bed unit within a Level I Trauma Center and Comprehensive Stroke Center with referrals from Canada to PA. Six Neuro-intensivists with diverse backgrounds.
@perfuseincuse Neuro ICU Fellowship
💪Level I trauma
🫁 Independent airway management
🧠EVD and intraparenchymal monitor insertion and management
🧠Comprehensive stroke center with high thrombectomy volume
💻Portable CT scanner and robotic TCD
https://t.co/NCAQvGPWOx
Congrats to all that matched for neurocritical care yesterday!
We have 1 spot available for an interested candidate in neurology, neurosurgery, anesthesia, IM, EM to start in July 2026
Please DM with interest
#ncc#neurocriticalcare#criticalcare#neurocrit
Great 2nd Upstate NY NCC Journal club with Dr. Steph Zyck presenting the ENRICH Trial. Encouraged by the excellent data on minimally invasive surgical evacuation of superficial ICH and taking steps for implementation. @AmcNeurology@URMC_Neurology@CHSBuffalo@UBNeurosci
@perfuseincuse Neuro ICU Fellowship
💪Level I trauma
🫁 Independent airway management
🧠EVD and intraparenchymal monitor insertion and management
🧠Comprehensive stroke center with high thrombectomy volume
💻Portable CT scanner and robotic TCD
https://t.co/NCAQvGPWOx
This single-center study found that MRI-based phenotyping of intracerebral hemorrhage according to the likely underlying causal arteriopathy is helpful in the stratification of recurrence risk. Read more: https://t.co/vDAjMSRjBe
#NeuroTwitter
Delphi consensus on Standards for Multimodality NeuroMonitoring (MNM). Overdue and important step to define core technology and skillsets for practice & training. Kudos to @NeuroLlama et al! @soojin_soojin @neurocritical@ACGME@CMSgov
https://t.co/jmlhVgHwpB
The use of video laryngoscopy for tracheal intubation in critically ill adults has increased over time, but whether outcomes are better with this approach than with direct laryngoscopy is uncertain.
Read the full DEVICE trial Research Summary: https://t.co/hi5TdfTZwG
Contemporary Incidence and Burden of Cerebral Venous Sinus Thrombosis in Children of the United States https://t.co/87yJCJtRet @ChaturvediNeuro@perfuseincuse@SmitdPat
Takeaways
- Large, well conducted trial on tx of delirium in the ICU
- Large portion of patients are hypoactive delirium
- Nonsig trend towards improved outcome in pt tx w/ haloperidol
- Primary outcome is clinically meaningful but difficult to impact with one intervention
Does standing haloperidol 2.5 mg q8h for patients with delirium improve # of days alive and out of hospital at 90 days?
RCT, ~1000 patients, Europe
No difference in primary outcome, no diff in adverse events
~55% patients with hypoactive delirium
https://t.co/5UUjBfxVQl
Trend towards benefit - albeit not statistically significant - especially in the hyperactive delirium subgroup
Interestingly, there was a small statistically significant decrease in mortality in the haloperidol group